Duke Investigator Receives National Institute of Allergy and Infectious Diseases Meritorious R37 Award
Wilton B. Williams, PhD, associate professor in surgery and co-director of the Duke Human Vaccine Institute (DHVI) Training and Mentoring Program (DTMP), was awarded the R37 meritorious award on June 3, 2024, from the National Institute of Allergy and Infectious Diseases (NIAID).
DHVI Faculty Appointments, Promotion, and Tenure - Kshitij Wagh, PhD
The Duke Human Vaccine Institute is pleased to announce that Kshitij Wagh, PhD, has been recruited to a faculty position in the Duke Human Vaccine Institute (DHVI), effective May 15, 2024.
DHVI faculty Appointments, Promotion, and Tenure - Daniel Wrapp, PhD
Duke Human Vaccine Institute (DHVI) is pleased to announce that Daniel Wrapp, PhD, has been promoted to the faculty position of assistant professor in the Department of Medicine at Duke, effective June 1, 2024.
Duke Human Vaccine Institute Accessioning Unit and Biorepository Receives International Organization of Standardization 20387 Biobanking Accreditation
The Duke Human Vaccine Institute (DHVI) Accessioning Unit and Biorepository (AUB) became an American Association of Laboratory Accreditation (A2LA) accredited biobank under the International Organization of Standardization (ISO) 20387:2018 standard in January 2024. DHVI’s AUB became one of only ten A2LA ISO 20387 accredited biobanks in the world.
Kevin Saunders Named Norman L. Letvin M. D. Distinguished Professor in Surgery and the Duke Human Vaccine Institute
This spring, 18 faculty members in the Duke University School of Medicine have been awarded distinguished professorships. The new distinguished professors will be honored at the annual distinguished professorship event on May 23, 2024.
In total, 32 new distinguished professors across Duke University were approved by the Board of Trustees in February.
Distinguished professorships are awarded to faculty who have demonstrated extraordinary scholarship in advancing science and improving human health.